This is the Tagline, edited under "Misc Content"
BIRMINGHAM, Ala., July 24, 2018 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), formerly known as HealthSouth Corp., today announced that its board of directors approved an increase in the Company's quarterly dividend of 8% and declared a quarterly cash dividend on its common stock of $0.27 per share, payable on Oct. 15, 2018, to holders of record on Oct. 1, 2018.
About Encompass Health
As a national leader in post-acute care, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that spans 128 hospitals and 268 home health & hospice locations in 36 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective care across the post-acute continuum. Driven by a set of shared values, Encompass Health is the result of the union between HealthSouth Corporation and Encompass Home Health & Hospice, and is ranked as one of Fortune's 100 Best Companies to Work For, as well as Modern Healthcare's Best Places to Work. For more information, visit encompasshealth.com, or follow us on Twitter and Facebook.
Statements contained in this press release which are not historical facts, such as dividend payment plans, are forward‑looking statements. In addition, the Company, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and the Company undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by the Company include, but are not limited to, the Company's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including its pending DOJ and HHS-OIG investigations and any matters related to yet undiscovered issues; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company's services by governmental or private payors; and other factors which may be identified from time to time in the Company's SEC filings and other public announcements, including its Form 10‑K for the year ended Dec. 31, 2017 and Form 10‑Q for the quarter ended March 31, 2018.
Casey Lassiter, 205 447-6410
Investor Relations Contact
Crissy Carlisle, 205 970-5860
SOURCE Encompass Health Corp.